Moderna Inc
MRNA
$238.59+5.43%
Delayed · as of Oct 15, 2026, 2:01 PM ET
Mkt cap
$24.52B
EV/Sales
11.6
P/E ratio
N/A
FY2025 Revenue
$1.94B
EPS (TTM)
$-7.98
Gross Margin (FY2025)
55.35%
Profit Margin (FY2025)
-145.16%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
Use this MRNA research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MRNA income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Moderna Inc (MRNA) is a biotechnology company in the Healthcare sector.
Latest cached Moderna Inc (MRNA) revenue for Dec 31, 2025 was $1.94B. Net income was -$2.82B. Statements: https://lician.com/financials/mrna
Moderna Inc (MRNA) market capitalization is $24.52B on the latest cached snapshot.
Moderna Inc (MRNA) cached previous close $226.30; day range $225.48 – $238.59; volume 12,161,641. Session quote: https://lician.com/quote/mrna
Moderna Inc (MRNA) latest cached earnings event is "MRNA earnings" on Aug 7, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MRNA filing is 8-K · Sep 30, 2026. Filings: https://lician.com/sec/mrna